| | | | |  |
Robert Taub, MBA
Chief Executive Officer and Director
| | Robert Taub has served as our chief executive officer and a member of our board of directors since the founding of OMRIX in 1995. Prior to establishing OMRIX, Mr. Taub was the cofounder of Octapharma A.G., a Swiss plasma fractionation and pharmaceutical company, which successfully introduced innovative plasma derivative products to the market. During his time at Octapharma, from 1983 to 1995, the company underwent a successful transformation from a start-up operation to an integrated manufacturing enterprise. He also founded a research and development group in Israel and initiated and directed the management of a biological fibrin sealant development project. Prior to Octapharma, Mr. Taub held various general management and sales and marketing positions with Armour Pharmaceutical, Revlon Health Care Group, Baxter Travenol Laboratories, Inc., now Baxter International Inc., and Monsanto Company. He has a B.A. in languages from the University of Antwerp and an M.B.A. from INSEAD (the European Institute of Business Administration) in Fontainebleau, France.
|
Nissim Mashiach, BSc, MpharmSc, MBA
President and Chief Operating Officer
| | Nissim Mashiach has served as our President and Chief Operating Officer since 2008. Mr. Mashiach joined OMRIX in 1998 as the Company’s plant manager and in 2000 was promoted to General Manager of OMRIX Biopharmaceuticals Ltd. In 2003 he was promoted to Senior Vice President and Chief Operating Officer and in 2006 to Executive Vice president and Chief Operating Officer. From 1991 to 1998, he served in various production and operations management positions with Perio Products Ltd., a privately held medical devices manufacturer located in Jerusalem, Israel. Mr. Mashiach holds a B.Sc. in chemical engineering from the Technion in Haifa, Israel, an Mpharm.Sc. from the Hebrew University in Jerusalem, Israel and an M.B.A. from the University of Manchester. |
Asaf Alperovitz
Chief Financial Officer
| | Asaf Alperovitz joined Omrix in 2008 as Chief Financial Officer. Prior to Omrix, from 2005 to 2008 Mr. Alperovitz was CFO of Tefron LTD, a multinational manufacturing company listed on both the New York (NYSE: TFR) and Tel-Aviv (TASE: TFRN) Stock Exchanges. From 2003 until 2005, Mr. Alperovitz was CFO of Corigin Ltd., an international enterprise software company. Prior to 2003, Mr. Alperovitz held a variety of management positions with Ernst & Young in Israel and the United States. His client-base included publicly traded companies in the U.S., Europe and Israel and his experience includes mergers and acquisitions as well as equity and debt public offerings. Mr. Alperovitz is a Certified Public Accountant and holds a Bachelor's degree in Accounting and Economics and a Masters in Business Administration from Tel-Aviv University. |
Marc Droppert
Executive Vice President
| | Marc Droppert joined Omrix in 2007 as Executive Vice President. Before joining Omrix, Marc was a partner and a member of the Board of Directors of Graham and Dunn, PC, with a practice focused on emerging-company transactions. He was previously employed by Physio-Control Inc. as Executive Vice President - Law, Human Resources and Business Development, and, following its going public and subsequently being sold to Medtronic, Inc., served as its Executive Vice President - Operations. Prior to Physio-Control, he was President of the Virginia Mason Health Plan (a Seattle-area HMO), and a senior executive of the Virginia Mason Medical Center. He previously served in a number of executive and legal positions, and has served as a member of a number of corporate and non-profit boards of directors. |
Nanci Prado
Vice President, General Counsel
| | Nanci Prado has served as our vice president, general counsel since August 2006. Prior to joining OMRIX, Ms. Prado was a partner in the Corporate Group of the New York office of Dorsey & Whitney LLP. Previously, she was an attorney in the Business and Technology Group in the New York office of Brobeck, Phleger & Harrison LLP. In these positions, Ms. Prado advised numerous public companies on a broad range of corporate governance, equity and debt financing, merger and acquisition and securities compliance issues. Ms. Prado was admitted to the New York Bar in 1995 and the California Bar in 2002. Ms. Prado received her J.D. degree from Stanford Law School. |
| |
| |
about us
